Published in BMC Genet on April 12, 2007
Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypes. Clin Immunol (2009) 1.14
Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun (2008) 1.00
Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS One (2010) 0.98
The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes Metab (2009) 0.86
Dominant sequences of human major histocompatibility complex conserved extended haplotypes from HLA-DQA2 to DAXX. PLoS Genet (2014) 0.85
Complete haplotype phasing of the MHC and KIR loci with targeted HaploSeq. BMC Genomics (2015) 0.76
HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02. PLoS One (2015) 0.75
Congruence as a measurement of extended haplotype structure across the genome. J Transl Med (2012) 0.75
The structure of haplotype blocks in the human genome. Science (2002) 50.88
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63
Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat Genet (2001) 15.53
On measures of gametic disequilibrium. Genetics (1988) 7.16
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
Reciprocal crossover asymmetry and meiotic drive in a human recombination hot spot. Nat Genet (2002) 4.07
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A (1998) 3.35
Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev (2004) 2.58
Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A (1983) 2.23
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens (2003) 1.46
Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region. Hum Mol Genet (2005) 1.38
Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes (2006) 1.38
The haplotype structure of the human major histocompatibility complex. Hum Immunol (2006) 1.29
Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes. Genomics (2006) 1.28
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J Immunol (1999) 1.26
Haplotype diversity and the block structure of linkage disequilibrium. Trends Genet (2002) 1.23
Serum complement 'supergenes' of the major histocompatibility complex in man (complotypes). Vox Sang (1983) 1.21
Multiple test procedures other than Bonferroni's deserve wider use. BMJ (1999) 1.17
Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun (2006) 1.08
Role of evolutionary history on haplotype block structure in the human genome: implications for disease mapping. Curr Opin Genet Dev (2003) 1.05
Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clin Sci (Lond) (2003) 1.04
Localized breakdown in linkage disequilibrium does not always predict sperm crossover hot spots in the human MHC class II region. Genomics (2005) 1.03
High and intermediate resolution DNA typing systems for class I HLA-A, B, C genes by hybridization with sequence-specific oligonucleotide probes (SSOP). Rev Immunogenet (1999) 0.98
Population genetic studies of HLA-E: evidence for selection. Hum Immunol (1997) 0.95
Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10. Nat Genet (2005) 0.93
HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes. Immunogenetics (2006) 0.89
Mechanisms of disease: infection and spondyloarthritis. Nat Clin Pract Rheumatol (2006) 0.89
Haplotype block and superblock structures of the alpha1-adrenergic receptor genes reveal echoes from the chromosomal past. Mol Genet Genomics (2004) 0.85
HLA-Cw*0409N is associated with HLA-A*2301 and HLA-B*4403-carrying haplotypes. Hum Immunol (2004) 0.81
Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes. Immunogenetics (1984) 0.81
Detection of HLA-E and -G DNA alleles for population and disease studies. Cell Mol Life Sci (1999) 0.80
Description of a new HLA-E (E*01031) allele and its frequency in the Spanish population. Hum Immunol (1997) 0.77
Genome-wide analysis of estrogen receptor binding sites. Nat Genet (2006) 18.63
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell (2005) 14.32
Biallelic inactivation of BRCA2 in Fanconi anemia. Science (2002) 9.31
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res (2005) 4.13
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. Blood (2004) 3.84
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res (2003) 3.39
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol (2006) 3.39
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms. Nat Med (2011) 2.34
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proc Natl Acad Sci U S A (2008) 2.27
Genomic mapping of RNA polymerase II reveals sites of co-transcriptional regulation in human cells. Genome Biol (2005) 2.11
Ethnic differences and functional analysis of MET mutations in lung cancer. Clin Cancer Res (2009) 2.03
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia. J Clin Oncol (2005) 1.91
FLT3 mutations in childhood acute lymphoblastic leukemia. Blood (2003) 1.91
Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One (2007) 1.72
The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med (2014) 1.49
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML. Blood (2014) 1.44
Mendelian inheritance of polygenic diseases: a hypothetical basis for increasing incidence. Med Hypotheses (2005) 1.39
Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood (2003) 1.38
p85 Associates with unphosphorylated PTEN and the PTEN-associated complex. Mol Cell Biol (2009) 1.36
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol (2008) 1.36
Exon expression profiling reveals stimulus-mediated exon use in neural cells. Genome Biol (2007) 1.35
The genetics of HLA-associated disease. Curr Opin Immunol (2004) 1.33
Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci U S A (2002) 1.31
The haplotype structure of the human major histocompatibility complex. Hum Immunol (2006) 1.29
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML. Blood (2004) 1.27
PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla. Immunity (2008) 1.27
Disputed maternity leading to identification of tetragametic chimerism. N Engl J Med (2002) 1.21
Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol (2012) 1.16
Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF). Development (2004) 1.11
Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth. FASEB J (2004) 1.09
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J Exp Med (2014) 1.09
Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol (2013) 1.07
Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J Clin Immunol (2003) 1.06
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proc Natl Acad Sci U S A (2011) 1.05
Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens. Cancer Res (2010) 1.04
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer Discov (2011) 1.02
CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol (2012) 1.00
Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett (2004) 0.98
CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation. Blood (2003) 0.97
HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLoS One (2013) 0.96
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res (2013) 0.95
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine (2009) 0.94
Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin Cancer Res (2006) 0.92
Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia. Br J Haematol (2011) 0.92
Anterograde tracing method using DiI to label vagal innervation of the embryonic and early postnatal mouse gastrointestinal tract. J Neurosci Methods (2007) 0.91
The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1. J Autoimmun (2007) 0.91
Complex expression of natural killer receptor genes in single natural killer cells. Immunology (2002) 0.90
Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis? Arthritis Res Ther (2005) 0.90
Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol (2009) 0.90
Increased short-term food satiation and sensitivity to cholecystokinin in neurotrophin-4 knock-in mice. Am J Physiol Regul Integr Comp Physiol (2004) 0.88
Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med (2013) 0.88
Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol (2009) 0.87
Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun (2006) 0.86
Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis. Proc Natl Acad Sci U S A (2013) 0.86
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells. Cancer Immunol Immunother (2012) 0.86
Mice deficient in brain-derived neurotrophic factor have altered development of gastric vagal sensory innervation. J Comp Neurol (2010) 0.86
HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells. J Clin Immunol (2002) 0.86
Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine. Toxicol Appl Pharmacol (2006) 0.86
Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican Americans. Hum Immunol (2006) 0.85
Vagaries of adipose tissue innervation. Am J Physiol Regul Integr Comp Physiol (2006) 0.84
Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Expert Opin Med Diagn (2008) 0.83
Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection. J Stem Cells (2007) 0.83
MHC class II genes in HCV viral clearance of hepatitis C infected Hispanic patients. Hum Immunol (2003) 0.82
Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L. J Clin Immunol (2006) 0.82
A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun (2006) 0.81
High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study. BMC Cancer (2009) 0.80
Male patients with diagnoses of both breast cancer and prostate cancer. Breast J (2003) 0.80
The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia. Immunogenetics (2003) 0.80
HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos. Hum Immunol (2004) 0.80
Genetic variations in toll-like receptor 4 in Mexican-Mestizo patients with intra-abdominal infection and/or pneumonia. Immunol Lett (2013) 0.80
Next-generation cDNA screening for oncogene and resistance phenotypes. PLoS One (2012) 0.80
Juvenile-onset loss of lipid-raft domains in attractin-deficient mice. Exp Cell Res (2006) 0.80